IL2 and Parkinson disease: Inflammatory pathways were also implicated; for instance, Saul Martínez-Horta et al. found elevated IL-2 and IL-6 levels in T2DM-PD patients with dementia, suggesting metabolic neuroinflammatory interactions [33].